Search

Steven A Keyser

from Evergreen, CO
Age ~63
Get Report
Also known as:
Steven Alan Keyser, Steve A Keyser, Steven A Er, Steven Pollini
Related to:
Pierre J Marsh, 84
Connected to:
Alice J Keyser, 89Alicia M Keyser, 48Ann M Keyser, 61April L Keyser, 50Bob J Keyser, 79Bonnie M Keyser, 76Caren F Keyser, 78Chadwick J Keyser, 53Chandra R Keyser, 51Charlotte K Keyser, 78

Steven Keyser Phones & Addresses

  • Evergreen, CO
  • 2120 700 E, Salt Lake City, UT 84106
  • Las Vegas, NV
  • Tucson, AZ
  • Evergreen, CO
  • 4619 Jupiter Dr, Salt Lake Cty, UT 84124

Business Records

Name / Title
Company / Classification
Phones & Addresses
Steven Keyser
M
Streamline Medical Management, Ltd
1504 Silver Oaks St, Las Vegas, NV 89117
4414 Hidden Oak Ct, Las Vegas, NV 89103
Steven Keyser
M
Corporate Medical Services, Ltd
6100 Carmen Blvd, Las Vegas, NV 89108
7620 Desert Largo Ave, Las Vegas, NV 89128
1504 Silver Oaks St, Las Vegas, NV 89117

Publications

Us Patents

Viral Inactivation Using Ozone

View page
US Patent:
20050051497, Mar 10, 2005
Filed:
Aug 2, 2004
Appl. No.:
10/910439
Inventors:
Joseph Latino - Brooklyn NY, US
Steven Keyser - Salt Lake City UT, US
International Classification:
C02F001/78
US Classification:
210739000, 210760000, 210764000
Abstract:
A method to inactivate viruses in a biological fluid and a non-fluid target to produce a non-infectious biological fluid or non-fluid target. The method involves subjecting an amount of a fluid or a target containing a virus including lipid-enveloped viruses, to an amount of ozone delivered by an ozone delivery system. The method may provide for maintaining the biological integrity of the biological fluid or the non-fluid target. All gas contacting surfaces of the system, including one or more gas-fluid contact devices are made from ozone-inert construction.

Ozone Delivery System Including Gas-Fluid Contacting Devices And Methods Of Use

View page
US Patent:
20050087498, Apr 28, 2005
Filed:
Aug 2, 2004
Appl. No.:
10/910485
Inventors:
Steven Keyser - Salt Lake City UT, US
Joseph Latino - Brooklyn NY, US
International Classification:
C02F001/78
US Classification:
210739000, 210760000, 210764000, 210192000
Abstract:
An ozone delivery system for delivering and manufacturing a measured amount of an ozone/oxygen admixture, which is able to measure, control, report and differentiate between delivered-ozone and absorbed-dose of ozone. Improved gas-fluid contacting devices that maximize gas-fluid mass transfer may be included. All gas contacting surfaces of the system, including one or more gas-fluid contacting devices are made from ozone-inert construction materials that generally do not absorb ozone or introduce amounts of contaminants or deleterious byproducts of oxidation into a fluid or non-fluid target from ozone oxidation.

Viral Inactivation Using Ozone

View page
US Patent:
20050189302, Sep 1, 2005
Filed:
Oct 11, 2004
Appl. No.:
10/963139
Inventors:
Joseph Latino - Brooklyn NY, US
Steven Keyser - Salt Lake City UT, US
International Classification:
C02F001/00
US Classification:
210739000
Abstract:
A method to inactivate viruses in a biological fluid and a non-fluid target to produce a non-infectious biological fluid or non-fluid target. The method involves subjecting an amount of a fluid or a target containing a virus including lipid-enveloped viruses, to an amount of ozone delivered by an ozone delivery system. The method may provide for maintaining the biological integrity of the biological fluid or the non-fluid target. All gas contacting surfaces of the system, including one or more gas-fluid contact devices are made from ozone-inert construction.

Treatment Of Inflammatory Disorders With Ozone

View page
US Patent:
20100316727, Dec 16, 2010
Filed:
Jun 21, 2010
Appl. No.:
12/819886
Inventors:
Joseph S. Latino - Brooklyn NY, US
Steven A. Keyser - Salt Lake City UT, US
International Classification:
A61K 33/40
A61K 35/14
A61K 35/16
A61P 29/00
A61P 9/08
A61P 37/02
A61P 3/10
A61P 1/00
A61P 17/06
A61P 9/10
A61P 25/28
A61P 25/00
A61P 25/24
A61P 19/02
A61P 11/00
A61P 25/16
US Classification:
424532, 424613, 424529, 424530
Abstract:
Methods for therapeutic treatment of inflammatory conditions in a mammalian patient provide clinical benefits including reduction of inflammation, vasorelaxation, reduction in edema and increased blood flow, the methods generally comprising extracorporeal treatment of blood, blood fractionate, or other biological fluid to expose such fluids to a precise, measured amount of ozone to produce a blood or biological fluid having a quantified absorbed dose of ozone, and reinfusing the treated biological fluid to the patient to provide therapeutic effects beneficial in the treatment of inflammatory disorders and related symptoms or conditions.

Treatment Of Cardiovascular Diseases With Ozone

View page
US Patent:
20100316730, Dec 16, 2010
Filed:
Jun 21, 2010
Appl. No.:
12/819875
Inventors:
Joseph S. Latino - Brooklyn NY, US
Steven A. Keyser - Salt Lake City UT, US
International Classification:
A61K 33/00
A61P 9/10
A61P 9/12
A61P 9/04
A61P 9/00
US Classification:
424613
Abstract:
Methods of treating cardiovascular diseases, including atherosclerosis, peripheral arterial occlusive disease, congestive heart failure, hypertension, cerebrovascular disease, dyslipidemia and vasospastic disorders such as Raynaud's disease, in a mammalian patient involve extracorporeally subjecting an amount of blood, blood fractionate or other biological fluid from a patient to a measured amount of ozone delivered by an ozone delivery system, resulting in the absorption of a quantifiable absorbed-dose of ozone and reinfusing the treated fluid into the patient to therapeutically treat cardiovascular disease and related conditions.

Treatment Of Acute Ischemic Brain Stroke With Ozone

View page
US Patent:
20100318014, Dec 16, 2010
Filed:
Jun 21, 2010
Appl. No.:
12/819871
Inventors:
Joseph S. Latino - Brooklyn NY, US
Steven A. Keyser - Salt Lake City UT, US
International Classification:
A61M 1/36
A61M 37/00
US Classification:
604 614, 604 24
Abstract:
Methods are provided for treatment of acute ischemic brain stroke based on the delivery of a measured amount of ozone to a sample of a mammalian patient's blood, blood fractionate or other biological fluid through the use of an ozone delivery system. The ozone-treated fluid, having absorbed a quantifiable absorbed-dose of ozone, is subsequently reinfused into the same patient and the autologous blood sample provides therapeutic effects to the patient, such as reduction in edema associated with the ischemic penumbra, improvement in impaired blood flow to the area surrounding the infarct, relaxation of the vascular endothelium and reduction of inflammation.

Ozone Delivery System Including Gas-Fluid Contacting Devices And Methods Of Use

View page
US Patent:
20110031172, Feb 10, 2011
Filed:
Jun 10, 2010
Appl. No.:
12/813361
Inventors:
Joseph S. Latino - Brooklyn NY, US
Steven A. Keyser - Salt Lake City UT, US
Assignee:
ACQUISCI, INC. - Belmar NJ
International Classification:
C02F 1/78
US Classification:
210 89
Abstract:
An ozone delivery system for delivering and manufacturing a measured amount of an ozone/oxygen admixture, which is able to measure, control, report and differentiate between delivered-ozone and absorbed-dose of ozone. Improved gas-fluid contacting devices that maximize gas-fluid mass transfer may be included. All gas contacting surfaces of the system, including one or more gas-fluid contacting devices are made from ozone-inert construction materials that generally do not absorb ozone or introduce amounts of contaminants or deleterious byproducts of oxidation into a fluid or non-fluid target from ozone oxidation.

Ozone Delivery System Including Gas-Fluid Contacting Devices And Methods Of Use

View page
US Patent:
20110031190, Feb 10, 2011
Filed:
Jun 10, 2010
Appl. No.:
12/813371
Inventors:
Joseph S. Latino - Brooklyn NY, US
Steven A. Keyser - Salt Lake City UT, US
Assignee:
ACQUISCI, INC. - Belmar NJ
International Classification:
C02F 1/78
G06F 19/00
US Classification:
210760, 702 45
Abstract:
An ozone delivery system for delivering and manufacturing a measured amount of an ozone/oxygen admixture, which is able to measure, control, report and differentiate between delivered-ozone and absorbed-dose of ozone. Improved gas-fluid contacting devices that maximize gas-fluid mass transfer may be included. All gas contacting surfaces of the system, including one or more gas-fluid contacting devices are made from ozone-inert construction materials that generally do not absorb ozone or introduce amounts of contaminants or deleterious byproducts of oxidation into a fluid or non-fluid target from ozone oxidation.
Control profile
Steven A Keyser from Evergreen, CO, age ~63 Get Report